Kalos Management, Inc. Abbott Laboratories Transaction History

Kalos Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Jun 21, 2022	SELL	$114.02 - $139.04 $229,864 - $280,304	-2,016 Closed	0 $0
Q4 2021 Feb 03, 2022	BUY	$115.53 - $141.46 $19,177 - $23,482	166 Added 8.97%	2,016 $251,000
Q3 2021 Nov 10, 2021	BUY	$116.66 - $129.06 $215,821 - $238,761	1,850 New	1,850 $231,000
Q4 2020 Feb 11, 2021	SELL	$105.0 - $114.42 $246,855 - $269,001	-2,351 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $215,445 - $261,642	2,351 New	2,351 $259,000

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $205B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Kalos Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Kalos Management, Inc. with notifications on news.